HealthCare Strategies adds Dr. Martin Graf to board

HealthCare Strategies named healthcare executive Dr. Martin Graf to its board of directors on Oct. 13, 2026, adding senior leadership experience in Medicare, Medicaid, Marketplace and pharmacy services. The company said the appointment supports its effort to identify high-risk members earlier and improve medical cost management for self-insured employers, labor funds, TPAs and health plans.

Why it matters: - HealthCare Strategies is adding a board member with deep experience in payer, provider and health system strategy. - The appointment strengthens the company’s focus on predicting high-cost claims before they hit health plans and employer-sponsored programs. - Dr. Graf’s background aligns with the populations and cost drivers HealthCare Strategies serves across Medicare, Medicaid, Marketplace and pharmacy benefits.

What happened: - HealthCare Strategies said Dr. Martin Graf joined its Board of Directors on Oct. 13, 2026. - Dr. Graf is a Senior Partner at Oliver Wyman. - Dr. Graf leads Oliver Wyman’s Health & Life Sciences Government Markets franchise and the Pharmacy Services franchise. - HealthCare Strategies is based in Columbia, Maryland. - The company serves self-insured employers, labor funds, TPAs and health plans.

The details: - Dr. Graf has more than 30 years of executive leadership and management consulting experience. - His experience spans payers, providers and health systems. - Before Oliver Wyman, Dr. Graf was a Partner at L.E.K. Consulting. - Dr. Graf also served as Chief Marketing Officer at UnitedHealth Group. - He started his career at United Technologies Corporation. - Dr. Graf holds two master’s degrees and a PhD from MIT. - Dr. Graf earned a Bachelor of Science with honors from the University of Miami. - HealthCare Strategies founder and operating model center on medical cost management for Taft-Hartley funds, labor-management coalitions, self-insured employers, TPAs, health plans and regional providers. - HCS was founded in 1982. - The company says a small share of members drives most health plan expenses, especially catastrophic claims and specialty drug costs. - HealthReach is the company’s predictive analytics engine. - HealthReach identifies high-risk members before claims arrive and pairs them with clinical expertise to build personalized care plans. - HealthCare Strategies says that approach produces better medical and financial outcomes.

Between the lines: - The board move appears designed to deepen HealthCare Strategies’ credibility with plan sponsors that care about early intervention and cost containment. - Dr. Graf’s Medicare, Medicaid and pharmacy background suggests a strategic focus on public-program complexity and drug-cost pressure. - His quote points to the company’s core pitch: find concentrated risk early, rather than paying for it after an expensive claim.

What's next: - Dr. Graf will support HealthCare Strategies as it expands its model to more plans, funds and employers. - The company is likely to keep emphasizing predictive analytics and clinical intervention as its differentiators. - More information is available in the company’s announcement.